Member Info for Hotfinance14

Thanks for the link Maggalus.

Good to see the Morocco 30 day trial will be completed in Q3 if all goes as planned.

If we can get an SP of 2p today it will be fantastic.

I am suprised Youness received some warrants for ther framework agreement. i always thought it was based on a commercial agreement.

I see Mark Whittle gave the linkedin post a like. Good to see he is still following the progress of Quadrise.

Boyporche....You have totally lost the plot. I have not moaned at all I have just stated how it is. A framework agreement!!!!

AKHM...It is only a framework agreement and that is why the SP has not moved much. When we get the Morocco commercial agreement then you will see some significant action in the SP.

Totally agree Gribbler.

I hope the trial starts soon. I recall one of our MMU's is in Denmark and I am not sure if the second one is still at Cepsa. Hopefully the MMU is shortly on it's way to Morocco.

No mention of biomsar in the trial or agreement.

SC....It is only a framework agreement. I doubt it will have a huge impact on the SP.

OCP Jorf Lasfar is a huge site :

https://www.youtube.com/watch?v=f8bihVnOg0I

Good to see our Morocco client is named in an RNS. A comment from the client would of been a nice bonus.

RIP John Potter

Nice RNS on OCP but i was expecting an actial signed commercial agreement.

Good lord the CEO of Tomco John Potter passed away on Friday.

I expect no news as per normal.

I would expect the next Valkor RNS to be around July/August stating samples tested with good results and Valkor received funding with the $1m paid to Quadrise.

Willswag...what RNS content are you expecting regarding Valkor ?

BNP Paribas seeks significant emission cuts from shipping clients:

https://splash247.com/bnp-paribas-seeks-significant-emission-cuts-from-shipping-clients/

Do we actually know when the MSC trial is expected to start ? I recall JM stating end of Q2 beginning of Q3 and then in a statement it stated H2.

Don't be surprised if we have no progress at all with Morocco and MSC this quarter and that in July we are told they are both delayed and therefore further funding required early next year.

This morning Astrazeneca announced that current revenues are $45bn and by 2030 they expect to deliver $80 billion Total Revenue. You can guarantee if JM was the CEO he would state the $80bn revenues are imminent.